CHARISSA Y CHANG, MD
Osteopathic Medicine in New York, NY

Gastroenterologist, Internist, Transplant Specialist

5 East 98Th Street, New York, NY 10029
168 Centre Street, Suite 3 M, New York, NY 10013

English

Martin P, Chang C. Update on the United States Hepatitis B Treatment Algorithm. Current Hepatitis Reports 2007;., Chang C, Singal A, Emre S, Schiano T, Lookstein R, Ganeshan S. Successful Use of Splenic Artery Embolization to Relieve Tense Ascites Following Liver Transplantation in a Patient with Budd Chiari Syndrome, Paroxysmal Nocturnal Hemoglobinuria, and Portal Vein Thrombosis: A Case Report. Liver Transplantation 2007; 13(11): 1532-1537., Schiano T, Chang C. Drug Hepatototoxicity Update. Alimentary Pharmacology and Therapeutics 2007; 25(10): 1135-1151., Caldwell S, Macik G, Chang C. Recombinant Activated Factor VII (rFVIIa) as a Hemostatic Agent in Liver Disease: A Break from Convention in Need of Controlled Trials. Hepatology 2004; 39(3): 592-598., Caldwell S, Krugner-Higby L, Nakamoto R, Chang C. The Mitochondria in Non-Alcoholic Fatty Liver Disease. Clinics in Liver Disease 2004; 8(3): 595-617., Chang C, Argo C, Caldwell S, Al-Osaimi A. Antioxidant Therapy in Non-Alcoholic Fatty Liver Disease. J Clin Gastroenterol 2005; 39(suppl 4)., Caldwell S, Chang C, Nakamoto R, Krugner-Higby L. Enlarged hepatocytes in NAFLD examined with osmium fixation: does microsteatosis underlie cellular ballooning in NASH?. Clinics in Liver Disease 2004; 8(3): 595-617., Westinghouse Science Talent Search Semifinalist, Research and Excellence Provost's Award for Undergraduate (Johns Hopkins University, Baltimore, Maryland - 1994), Tau Beta Pi (Johns Hopkins University - 1994), Advanced Hepatology Fellowship Grant (American Association of Liver Diseases - 2005), Chang C, Argo C, Caldwell S, Al-Osaimi A. Antioxidant Therapy in Non-Alcoholic Fatty Liver Disease. J Clin Gastroenterol 2005; 39(suppl 4)., Chang CY, Martin P, Fotiadu A, Hytiroglou P. A patient with chronic hepatitis B and regression of fibrosis during treatment. Seminars in liver disease 2010 Aug; 30(3)., Tan HH, Chang CY, Martin P. Acetaminophen hepatotoxicity: current management. The Mount Sinai journal of medicine, New York 2009 Feb; 76(1)., Tuyama AC, Chang CY. Non-alcoholic fatty liver disease. Journal of diabetes 2012 Sep; 4(3)., Ward SC, Chang CY, Peng L, Liu LU. Patient with hepatitis B and alcoholic liver disease before and after liver transplantation. Seminars in liver disease 2009 May; 29(2).

American Board of Internal Medicine, Transplant Hepatology (Internal Medicine), Gastroenterology (Internal Medicine)

Gastroenterology, Transplant Hepatology

50

MOUNT SINAI MEDICAL CENTER
1 Gustave L Levy Pl SUITE 1104, New York 10029
(212) 241-8035 (Phone), (212) 996-9688 (Fax)

Gastroenterology, 2005, Internal Medicine, 2002, Transplant Hepatology, 2006

Healthgrades Honor Roll

English

Internal Medicine, Gastroenterology, Transplant Hepatology, Hepatology

Mt Sinai Hospital
5 E 98Th St, New York, NY 10029 New York University - Mount Sinai
1 Gustave L Levy Pl, New York, NY 10029

University of Maryland(1999)